Successful bid secures funding for severe asthma treatment

Asthma teams across the South West are encouraged to get involved in creating a common pathway for managing asthma care and improving access to asthma biologic therapy. 

New funding available to transform patient lives

A successful bid of £129,000 funding from the NHS Pathway Transformation Fund (PTF), incorporating selected Rapid Uptake Products, has been awarded for the treatment of severe asthma.

The bid collaboration between South West and West of England AHSNs, and the South West Asthma Network, means support is now available to 10 Trusts across the South West of England from Cornwall to Bristol in addition to Bristol Royal Hospital for Children. The two AHSNs will be working alongside the South West Severe Asthma Network, Clinical Commissioning Groups (CCGs) and Acute Trusts to implement the bid objectives

Rapid Uptake Products (RUP) programme identifies products with NICE approval (the National Institute for Health and Care Excellence) which contribute to key clinical priorities, with lower-than-expected uptake. The programme supports the deeper adoption and spread of these proven innovations in the NHS. The Pathway Transformation Fund (PTF) helps support the integration of chosen Rapid Uptake Products into everyday practices to overcome barriers to their use.

Asthma Biologics

Asthma Biologics have been selected as one of the Rapid Uptake Products for 2021/22. These specialist medicines can be made available to treat people with severe asthma who continue to experience asthma attacks despite taking usual treatments.

Asthma biologic therapies can transform the lives of patients with severe asthma through the availability of better treatment options. They help reduce the long-term side effects of traditional asthma treatments and can reduce the frequency of aggravated, life-threatening asthma attacks.

How new funding will be applied

Funding is available for each hospital across the region.

The South West Severe Asthma Network (SWAN) will work with all hospitals to create a common pathway for managing asthma care. The aim is to streamline the referral process to severe asthma centres and improve access to asthma biologic therapy. The SWAN will form a working group involving medical and nursing representatives from each of the Trusts across the South West, supported by a project manager.

This means that each hospital across the region can receive funding to support 2 hours of extra Consultant time and 2 hours extra of Respiratory Nurse time per week to deliver the objectives specified within the bid application.

The bid also allocates funds for enabling Asthma biologic access in children with severe asthma through Bristol Royal Hospital for Children.

Get involved

We’re encouraging all asthma teams across the South West to get involved in this work, including those that refer patients outside the South West region. For more information please contact the South West AHSN’s RUP lead and Programme Manager Steve Johnson-Wood.

You may also be Interested in

Testing the potential of AI logistics technology to support the home care workforce

Testing the potential of AI logistics technology to support the home care workforce

Read more
New evaluation shows quality improvement project is improving care for premature babies

New evaluation shows quality improvement project is improving care for premature babies

Read more
Mental health teams brought together to improve patient safety and health equity 

Mental health teams brought together to improve patient safety and health equity 

Read more
Newsletter

Stay up to date

Sign up to our newsletter for all the latest news and events